SOURCE: OR-Live, Inc.

April 30, 2008 07:15 ET

REMINDER: ORLive Presents: Component Separation for Complex Abdominal Wall Reconstruction

Live Webcast: From Albany Medical Center: April 30, 2008 at 7:00 PM EDT (23:00 UTC)

ALBANY, NY--(Marketwire - April 30, 2008) - On Wednesday, April 30, 2008, at 7pm EDT, OR-Live will broadcast a component separation for complex abdominal wall reconstruction from Albany Medical Center in Albany, New York. This procedure will be performed by Jerome D. Chao, MD, FACS, Assistant Professor of Surgery, Director, Plastic Surgery Trauma - Department of Surgery, Division of Plastic Surgery, Albany Medical College, and Dimitri J. Koumanis, MD, Assistant Professor of Surgery, Department of Surgery, Division of Plastic Surgery, Albany Medical College. Dr. Chao and Dr. Koumanis will perform this component separation using Veritas® Collagen Matrix ("Veritas"), an innovative biologic material which remodels into the tissue it is used to repair. Veritas is a tested, FDA cleared and exciting alternative to currently available synthetic and biologic meshes. Questions from healthcare professionals and the general public can be sent to Dr. Chao and Dr. Koumanis during the broadcast and the seven days following. Dr. Chao and Dr. Koumanis will address questions during this period as time permits.

Veritas Collagen Matrix, from Synovis Life Technologies, is an innovative non-cross-linked biologic material derived from bovine pericardium indicated for use as an implant for the surgical repair of soft tissue deficiencies, including abdominal wall and thoracic wall repair, muscle flap reinforcement, and repair of hernias. Veritas is produced through a patented process that results in an extremely biocompatible and highly acellular remodelable material. Once implanted, Veritas provides a scaffold for connective tissue protein synthesis and host tissue in-growth. The result is the seamless integration of Veritas into the surrounding host tissue.

Veritas has been used successfully in contaminated wounds and in the presence of infection as well as in other challenging situations. The U.S. Food and Drug Administration (FDA) granted Synovis the following additional indication: Veritas minimizes tissue attachment to the material when in direct contact with viscera. Veritas is the first biologic to have received this important indication from the FDA.

Veritas has been used successfully in a variety of surgical procedures including: complex abdominal wall repair, laparoscopic hiatal hernia repair, chest wall reconstruction, and breast reconstruction.

Dr. Jerome Chao is a plastic surgeon and assistant professor of surgery at Albany Medical Center. He is a 1990 graduate of Harvard University, and received his medical degree from the College of Physicians and Surgeons of Columbia University. Dr. Chao trained at McGaw Medical Center of Northwestern University in Chicago, and The New York Orthopaedic Hospital of Columbia University Medical Center.

Dr. Chao specializes in aesthetic surgery, reconstructive surgeries including breast reconstruction, hand surgery, skin cancer surgery, peripheral nerve surgery, post-bariatric plastic surgery and wound healing.

Dr. Jim Koumanis also serves as a plastic surgeon and assistant professor of surgery at Albany Medical Center. He has extensive training from Nassau University Medical Center, Indiana University and McGill University in Montreal, Canada. He received his medical degree from the University of Western Ontario.

Dr. Koumanis specializes in microsurgery, burns and aesthetic surgery, and complex reconstructive surgery due to trauma and cancer.

Albany Medical Center is northeastern New York's only academic health sciences center. It consists of Albany Medical College, Albany Medical Center Hospital and the Albany Medical Center Foundation, Inc. Additional information about Albany Medical Center can be found at www.amc.edu.

About Synovis Life Technologies

Synovis Life Technologies, Inc. (NASDAQ: SYNO), based in St. Paul, Minn., is a diversified medical device company engaged in developing, manufacturing, and bringing to market medical devices for the surgical treatment of disease. For additional information on Synovis Life Technologies and its businesses, visit the company's Web site at www.synovislife.com.

Visit: http://www.or-live.com/synovissurgical/1928 to learn more and view a program preview. VNR: http://www.or-live.com/rams/syl-1928-mkw-q.ram

Contact Information

  • Contact:
    Alex Fraser
    Director of Marketing
    OR-Live, Inc.
    860-953-2900 x 214
    afraser@orlive.com